Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of high-dose ropivacaine with and without epinephrine in combined femoral and sciatic nerve block
2009-013481-10Phase 4Active
- Sponsor
- Sint Maartenskliniek
- Start
- Aug 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in perioperative pain (2 arms), sponsored by Sint Maartenskliniek. Primary endpoints: Mean unbound and bound peak plasma concentration (Cmax) of ropivacaine with epinephrine and Mean unbound and bound peak plasma concentration (Cmax) of ropivacaine without epinephrine. Started Aug 2009; status: active.
02
Drugs
ropivacaine
03
Conditions
perioperative pain
Beyond the preview
Go deeper on 2009-013481-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013481-10.